Sharp Sword! The FTC sues three major pharmaceutical 'middlemen', vowing to correct the distorted chain of interests.
①The USA FTC announced on its official website that it has filed a lawsuit against three major pharmaceutical benefit managers and their affiliated organizations, accusing them of engaging in anti-competitive and unfair rebate practices; ② The FTC also "explicitly stated" in the declaration that it is deeply concerned about the roles played by Eli Lilly, Novo-Nordisk, and Sanofi, insulin pharmaceutical companies, and may suggest in future enforcement actions to prosecute these pharmaceutical manufacturers.
Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation
Affinia Therapeutics Appoints Rami Daoud as Chief Business and Financial Officer
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Latest Research Highlighting VASCEPA/VAZKEPA (Icosapent Ethyl) REDUCE-IT Subgroup Data and New Mechanistic Insights Into Eicosapentaenoic Acid (EPA) to Be Presented at European Society of Cardiology (ESC) Congress
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Open Week Strong Monday Trading
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Amarin's Stock Maintains Hold Rating Amidst Revenue Highs and Market Challenges
Analysts Have Been Trimming Their Amarin Corporation Plc (NASDAQ:AMRN) Price Target After Its Latest Report
Amarin's Sell Rating Upheld Amid Revenue Concerns and Market Access Challenges
Express News | Amarin Shares Are Trading Lower. The Company Reported Q2 Financial Results
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
Amarin | 10-Q: Q2 2024 Earnings Report
Earnings Flash (AMRN) AMARIN CORPORATION Posts Q2 Revenue $67.5M, Vs. Street Est of $51M
Express News | Amarin Corp - Qtrly Shr $0.00